# Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum

> **NCT02323438** · NA · COMPLETED · sponsor: **R.J. Reynolds Vapor Company** · enrollment: 153 (actual)

## Conditions studied

- Smoking

## Interventions

- **OTHER:** Usual Brand Cigarette
- **OTHER:** Electronic Cigarette #1
- **OTHER:** Electronic Cigarette #2
- **OTHER:** Leading U.S. Nicotine Gum

## Key facts

- **NCT ID:** NCT02323438
- **Lead sponsor:** R.J. Reynolds Vapor Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2018-06-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323438, "Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02323438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*